Exosome Diagnostics and Therapeutics: Global Markets

Published - Jun 2019| Analyst - Bhavna Joshi| Code - BIO149C
Exosome Diagnostics and Therapeutics: Global Markets
Single User License: $5500 Member Price: FREE

Report Highlights

The global market for exosome diagnostics and therapeutics should grow from $34.7 million in 2018 to $186.2 million by 2023, with a compound annual growth rate (CAGR) of 39.9% for the period of 2018-2023.

Report Includes

  • 106 tables
  • An overview of the global market for exosome diagnostics and therapeutics
  • Analyses of global market trends, with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Description of immunological compatibility, cargo capabilities and other intrinsic therapeutic activities of exosomes
  • Details of isolation and detection techniques and description of reagents and tools used for exosome research
  • Evaluation of exosomal proteins and nucleic acids as diagnostic biomarkers and discussion of their impact on microRNA, liquid biopsy and stem cell research industry
  • Information on bioinformatics databases for exosome research and product development, including as ExoCarta, Vesiclopedia and EVpedia
  • Company profiles of the prominent players, including Codiak BioSciences, Evox Therapeutics Ltd., Exosome Diagnostics Inc., HansaBioMed Life Sciences Ltd. (Lonza), NonoSomiX Inc., and System Biosciences (SBI)

Report Scope

This report represents a current and important business tool to evaluate new commercial opportunities in the exosome diagnostic, therapeutic and research tool markets. The geographic scope of this study covers the U.S. and companies worldwide. This market is complex and consists of a number of different sectors, each affected differently by scientific and technological development. The report identifies the main positive and negative factors in each sector and forecasts further trends and product and assay development in every category of this industry.

Analyst Credentials

Bhavna Joshi has more than 10 years of experience in healthcare and biotechnology research. In addition to business research and consulting, she has conducted corporate briefings for top players in a wide range of market segments. She holds an MBA in marketing and finance from Chennai University and has worked with major market research firms.

Bhavna Joshi has authored several market research studies on subjects in the healthcare domain, including:

  • Healthcare tracking technologies.
  • Molecular diagnostics market.
  • High-growth markets in healthcare and life sciences.
  • Adoption rates and analysis of over the counter (OTC) diabetic medicines and supplements.
  • Radio frequency identification (RFID), real-time locating systems (RTLS), internet protocol (IP) surveillance, and other emerging technologies in the healthcare domain.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
 
Published - Jun-2018| Analyst - Marianna Tcherpakov| Code - BIO149B

Report Highlights

The global market for exosome industry should reach $180.0 million by 2023 from $25 million in 2018 at a compound annual growth rate (CAGR) of 48.4% for the period 2018-2023.

Report Includes

  • 35 data tables and 35 additional tables
  • An overview of the global markets and related technologies for exosome diagnostics and therapeutics
  • Analyses of global market trends, with data from 2016 to 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Breakdowns of new and existing diagnostic methods
  • Evaluations of current therapeutics and those likely to be utilized in the near future
  • Analyses of the market’s dynamics, specifically growth drivers, restraints, and opportunities
  • Company profiles of major players in the market, including Codiak BioSciences, Evox Therapeutics, Exosome Diagnostics, Inc., HansaBioMed, NonosomiX, Inc. and System Biosciences (SBI)
Published - Mar-2016| Analyst - Marianna Tcherpakov| Code - BIO149A

Report Highlights

The global market for exosome diagnostics and therapeutics is projected to grow from $16.1 million in 2016 to $111.8 million in 2021, a five-year compound annual growth rate (CAGR) of 47.3%.

Report Includes

  • An overview of the global markets and related technologies for exosome diagnostics and therapeutics.
  • Analyses of global market trends, with data from 2015, estimates for 2016, and projections of CAGRs through 2021.
  • Breakdowns of new and exisiting diagnostic methods.
  • Evaluation of current therapeutics and those likely to be realized in the near future.
  • Analyses of the market's dynamics, specifically growth drivers, restraints, and opportunities.
  • Profiles of major players in the industry.
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report